Skip to main content

Autonomix Medical, Inc.

AMIX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001617867

No open-market purchases or sales by Autonomix Medical, Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $30.3K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Autonomix Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Autonomix Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Autonomix Medical, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Smith Trent N.CFO15,119Sep 21, 20261
Klemp Walter VDirector20,118Sep 8, 20261
Bisson LoriDirector13,119Sep 8, 20261
Hauser BradleyCEO and President27,000Sep 8, 20261
Capelli ChristopherDirector–Aug 13, 20250
Robins David AndrewDirector–Jul 26, 20240
BioStar Ventures III, L.P.10% Owner–Jun 20, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 26, 2024 (view filing)Jun 1838 daysLateRobins David AndrewDirectorPPurchase+104.0K$0.00$0–110.2K afterDerivative
Jun 20, 2024 (view filing)8:23 PM ETJun 182 daysBioStar Ventures III, L.P.10% OwnerPPurchase+1.09M$0.028+$30.5K–1.09M afterDerivative